• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Bluejay To Present Abstract At 2026 SAEM Annual Meeting

    GLOBENEWSWIRE

    Bluejay Diagnostics Updates Corporate Status And 2026 Strategy

    GLOBENEWSWIRE

    Bluejay Diagnostics Announces 1-For-4 Reverse Stock Split

    GLOBENEWSWIRE

    Bluejay Diagnostics Advances Clinical Milestones And Partnerships

    GLOBENEWSWIRE

    Bluejay Diagnostics Complete $4.5M Private Placement Under Nasdaq

    GLOBENEWSWIRE

    Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership

    GLOBENEWSWIRE

    Bluejay Diagnostics Reveals $4.5M Private Placement Under Nasdaq

    GLOBENEWSWIRE

    SYMON-I of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

    GLOBENEWSWIRE

    Bluejay Announces Initiation of Study Evaluating Symphony IL-6

    GLOBENEWSWIRE

    Bluejay Announces $1.59M Registered Direct Offering Priced under Nasdaq Rules

    GLOBENEWSWIRE

    Bluejay Diagnostics Reports Second Quarter 2023 Financial Results

    GLOBENEWSWIRE

    Bluejay Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement

    GLOBENEWSWIRE

    Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

    GLOBENEWSWIRE

    Bluejay Diagnostics Reports First Quarter 2023 Financial Results

    GLOBENEWSWIRE

    Bluejay Diagnostics Reports 2022 Financial Results

    GLOBENEWSWIRE

    Bluejay to Host Opinion Leader Event on IL-6 Testing in Critical Care Settings

    GLOBENEWSWIRE

    Bluejay raises $41 million in Series B round to drive clinical trials

    GLOBENEWSWIRE

    Positive Clinical Results for Bluejay’s Symphony IL-6 Test at AACC 2022

    GLOBENEWSWIRE

    Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

    GLOBENEWSWIRE

    FDA Agrees to Consider Bluejay`s Plan to Pursue De Novo Regulatory Pathway

    GLOBENEWSWIRE

    Bluejay Diagnostics Appoints Edwin Rule as VP, Regulatory, Quality, Compliance

    GLOBENEWSWIRE

    Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

    GLOBENEWSWIRE

    Bluejay Diagnostics, Inc. Reports Q4 and FY 2021 Financial Results

    GLOBENEWSWIRE

    Bluejay Diagnostics Announces its Pre-Submission Filing Package

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.